2,5-dipentyl-[1,3,4]oxadiazole | 13044-02-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2,5-dipentyl-[1,3,4]oxadiazole
• 英文别名: 2,5-Dipentyl-1,3,4-oxadiazole
• CAS: 13044-02-5
• 化学式: C₁₂H₂₂N₂O
• 分子量: 210.319
• InChiKey: YHSAOGDMLDJGPA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  15
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  38.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  己酸 生成 2,5-dipentyl-[1,3,4]oxadiazole
  参考文献：
  名称：

  2, 5-Dialkyl-1, 3, 4-oxadiazoles

  摘要：

  DOI：

  10.1007/bf00480711

文献信息

• ACYL-HYDRAZONE AND OXADIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF
  申请人：Universidade Federal de Santa Catarina

  公开号：US20150191445A1

  公开（公告）日：2015-07-09

  The present invention relates to acyl-hydrazone compounds, in particular 3,4,5-trimethoxyphenyl-hydrazide derivatives, as well as the oxadiazole analogs thereof and other similar compounds, and to the pharmaceutical use of the same for the treatment of various diseases associated with cell proliferation, such as leukemias, including acute lymphoblastic leukemia (ALL), tumours and inflammation. Acyl-hydrazones have been obtained having activity similar to that of the compound used as a standard in experiments (colchicine). The greater selectivity of the compounds according to the invention is an important feature, associated with fewer side effects than the pharmaceuticals used at present in clinical treatments. The synthetised acyl-hydrazones, more particularly the compounds 02 and 07, exhibited important antileukemic activity, which suggests 02 and 07 as candidates to pharmaceutical prototypes, or to pharmaceuticals for the treatment of leukemias, in particular acute lymphoblastic leukemia (ALL), tumours and other proliferative diseases, such as inflammation. The action mechanism of the most active compounds was determined by using DNA microarrays and subsequent tests indicated by the chip, besides selectivity studies in healthy human lymphocytes.

  本发明涉及酰基腙化合物，特别是3,4,5-三甲氧基苯基腙衍生物，以及其噁二唑类似物和其他类似化合物，以及它们在治疗与细胞增殖相关的各种疾病，如白血病（包括急性淋巴细胞白血病（ALL））、肿瘤和炎症方面的药用。已获得具有与实验中使用的化合物（秋水仙碱）相似活性的酰基腙。根据本发明的化合物具有更大的选择性，与目前在临床治疗中使用的药物相比，副作用更少是一个重要特征。合成的酰基腙，尤其是化合物02和07，表现出重要的抗白血病活性，这表明02和07可能成为药物原型的候选，或用于治疗白血病，特别是急性淋巴细胞白血病（ALL）、肿瘤和其他增殖性疾病，如炎症的药物。最活性化合物的作用机制是通过使用DNA微阵列确定的，并且通过芯片指示的后续测试，以及对健康人类淋巴细胞的选择性研究。
• [EN] ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY<br/>[FR] MATIÈRES DE TRANSPORT D'ÉLECTRONS POLYMÉRISABLES PAR OUVERTURE DE CYCLE PAR MÉTATHÈSE(ROMP) À BASE D'UNE FRACTION BIS-OXADIAZOLE
  申请人：GEORGIA TECH RES INST

  公开号：WO2009080797A1

  公开（公告）日：2009-07-02

  This invention relates generally to a solution processable norbornene monomer, poly(norbornene) homopolymer, and poly(norbornene) copolymer compounds containing a functionalized bis -oxadiazole side chain, and to an electron injecting/transporting layer, a hole -blocking layer, or an emissive material, organic electronic devices and compositions which include these compounds.

  这项发明涉及一种可溶解的去甲基环戊烯单体、聚（去甲基环戊烯）均聚物和含有功能化双-噁二唑侧链的聚（去甲基环戊烯）共聚物化合物，以及电子注入/传输层、阻挡孔层或发光材料、有机电子器件和包括这些化合物的组合物。
• [EN] POLYMERIZABLE AMBIPOLAR HOSTS FOR PHOSPHORESCENT GUEST EMITTERS<br/>[FR] HÔTES AMBIPOLAIRES POLYMÉRISABLES POUR ÉMETTEURS INVITÉS PHOSPHORESCENTS
  申请人：GEORGIA TECH RES INST

  公开号：WO2010149620A1

  公开（公告）日：2010-12-29

  The inventions describe disclosed and described herein relate to polymerizable ambipolar monomers, useful for making polymer or copolymer host materials for guest phosphorescent metal complexes, which together can form emission layers of organic light emitting diodes (OLEDs). Methods of making the ambipolar monomers are also described. Formula (I) wherein at least one of the R1, R2 and R3 groups is an optionally substituted carbazole group.

  本发明涉及可聚合的两性单体，用于制备用于客体磷光金属配合物的聚合物或共聚物基体材料，二者共同形成有机发光二极管（OLEDs）的发射层。还描述了制备两性单体的方法。其中，至少有一个R1、R2和R3基团是可选择取代的咔唑基团的化学式（I）。
• FACILE PREPARATION OF 4-SUBSTITUTED QUINAZOLINES AND RELATED HETEROCYCLES
  申请人：Wang Zerong Daniel

  公开号：US20120283436A1

  公开（公告）日：2012-11-08

  A straightforward single step method for the preparation and/or production of substituted quinazolines is disclosed, wherein said quinazolines preferably contain one substituent at position 4, and may contain other functional groups at various positions, such as 5, 6, 7, and/or 8 of quinazolines. In addition, the extension of this new method leads to the formation of different type of heterocyclic aromatic compounds, that include but are not limited to perimidines, anthrapyrimidin-7-ones (also known as anthrapyrimidinones), anthra[1,9:5,10]dipyrimidines (also known as quinazoline[5,4-ef]perimidines) and benzo[e]-pyrimido[4,5,6-gh]pyrimidines.

  本发明揭示了一种制备和/或生产取代喹唑啉的简单单步方法，其中所述喹唑啉优选在位置4处含有一个取代基，并且可能在喹唑啉的各种位置，例如5、6、7和/或8处含有其他官能团。此外，这种新方法的扩展还导致不同类型的杂环芳香化合物的形成，包括但不限于咪唑啉、蒽吡咯啉-7-酮（也称为蒽吡咯啉酮）、蒽[1,9:5,10]二咪唑啉（也称为喹唑啉[5,4-ef]咪唑啉）和苯并[e]-嘧啶[4,5,6-gh]嘧啶。
• Method for preparing light-absorbing polymeric compositions
  申请人：——

  公开号：US20040195552A1

  公开（公告）日：2004-10-07

  The present invention recites a method comprising reacting in a solvent in the presence of a base a) at least one diacidic monomer comprising about 1 to 100 mole % of at least one light-absorbing monomer having a light absorption maximum between about 300 nm and about 1200 nm and 99-0 mole % of a non-light absorbing monomer which does not absorb significant light at wavelengths above 300 nm or has a light absorption maximum below 300 nm, with b) an organic compound of Formula II X—B—X 1 wherein B is a divalent organic radical to form a light absorbing composition comprising a mixture of a polymer having the formula 1 and a cyclic compound having the general formula 2 wherein B is as defined above; n is at least 2, m is 1, 2, 3 or 4 and A comprises the residue of a diacidic monomer comprising about 1 to 100 mole % of at least one light-absorbing monomer having a light absorption maximum between about 300 nm and about 1000 nm and wherein the remaining portion of A comprises the residue of a non-light absorbing monomer which does not absorb significant light at wavelengths above 300 nm or has a light absorption maximum below 300 nm.

  本发明涉及一种方法，包括在溶剂中，在碱的存在下反应：a）至少一种二酸单体，其中包括约1至100摩尔％的至少一种具有在300nm至1200nm之间的光吸收最大值的光吸收单体和99-0摩尔％的不吸收在300nm以上波长处的显著光或具有在300nm以下的光吸收最大值的非光吸收单体；b）式IIX-B-X1的有机化合物，其中B是二价有机基团，以形成一种光吸收组合物，该组合物包括具有式1的聚合物和具有一般式2的环状化合物，其中B如上所定义；n至少为2，m为1、2、3或4，A包括约1至100摩尔％的至少一种具有在300nm至1000nm之间的光吸收最大值的光吸收单体的残基，其中A的其余部分包括不吸收在300nm以上波长处的显著光或具有在300nm以下的光吸收最大值的非光吸收单体的残基。